Skip to content
  • EnglishEnglish
  • SvenskaSvenska
 

ASCELIA

AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY

  • About us
    • Management
    • Board of Directors
  • Diseases
    • Liver metastases
    • Gastric Cancer
  • Pipeline
    • Mangoral
    • Oncoral
  • Partnering
  • IR & Media
    • Press releases
    • Reports & Presentations
    • Share
    • Shareholders
    • Equity research
    • Subscribe to press releases
    • Ascelia Pharma in Media
    • IPO (completed 2019)
    • IR Contact
    • Financial calendar
    • CMD 2020
    • Events
  • Governance
    • General Meeting
    • Articles of Association
    • Nomination Committee
    • Board of Directors
    • Audit Committee
    • Remuneration Committee
    • Commercialization Committee
    • Remuneration
    • Auditors
    • Internal control
  • Career
    • Open positions
    • Open applications
    • Our values
    • Meet us
  • Contact
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
All All press releasesRegulatory press releasesFinancial reports
Regulatory
2021-04-09 | Issue and repurchase of series C shares for share saving program
Download
Presentation
Webcast
Excel
Regulatory
2021-03-31 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
Download
Presentation
Webcast
Excel
Regulatory
2021-03-17 | Notice of extraordinary general meeting in Ascelia Pharma
Download
Presentation
Webcast
Excel
Regulatory
2021-02-16 | Quarterly Report Q4 2020: Mangoral shows high diagnostic value in new study
Download
Presentation
Webcast
Excel
Regulatory
2020-11-05 | Quarterly Report Q3-2020: Raised market estimate for Mangoral and preparing for market launch
Download
Presentation
Webcast
Excel
Regulatory
2020-05-13 | Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE
Download
Presentation
Webcast
Excel
Regulatory
2020-05-06 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 6 May 2020
Download
Presentation
Webcast
Excel
Regulatory
2020-04-03 | Ascelia Pharma’s Nomination Committee proposes election of Lauren Barnes to the Board of Directors
Download
Presentation
Webcast
Excel
Regulatory
2020-04-03 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
Download
Presentation
Webcast
Excel
Regulatory
2020-03-02 | Issue and repurchase of series C shares for share saving program
Download
Presentation
Webcast
Excel
Regulatory
2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE
Download
Presentation
Webcast
Excel
Regulatory
2019-12-18 | Nomination Committee appointed for AGM 2020 in Ascelia Pharma AB
Download
Presentation
Webcast
Excel
Regulatory
2019-12-06 | Ascelia Pharma appoints Julie Waras Brogren as Chief Commercial Officer
Download
Presentation
Webcast
Excel
Regulatory
2019-11-14 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 14 November 2019
Download
Presentation
Webcast
Excel
Regulatory
2019-11-08 | Preparations for Phase III study with Mangoral[®] on track
Download
Presentation
Webcast
Excel
Regulatory
2019-10-25 | Change in Ascelia Pharma’s management team
Download
Presentation
Webcast
Excel
Regulatory
2019-10-14 | Notice of Annual General Meeting of Ascelia Pharma AB
Download
Presentation
Webcast
Excel
Regulatory
2019-08-22 | Phase III study of Mangoral to start in H2-2019
Download
Presentation
Webcast
Excel
Regulatory
2019-05-15 | Fully financed Phase III program for Mangoral through the IPO
Download
Presentation
Webcast
Excel
Regulatory
2019-05-10 | Nomination Committee appointed for AGM 2019 in Ascelia Pharma AB
Download
Presentation
Webcast
Excel

Posts navigation

Older posts

  • Ascelia Pharma AB

  • Hyllie Boulevard 34

  • 215 32 MALMÖ

  • Sweden

  • +46 735 179 118

Ascelia Pharma © 2019 | All Rights Reserved

Privacy policy Ascelia Pharma AB

Video
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
  • Necessary
    These cookies are not optional. They are needed for the website to function.
  • Statistics
    In order for us to improve the website's functionality and structure, based on how the website is used.
  • Experience
    In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
  • Marketing
    By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save Accept all